Immuneering Corp is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMRX is expected to report earnings to fall 15.52% to -49 cents per share on May 13
Q1'25
Est.
$-0.49
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.01
The last earnings report on March 20 showed earnings per share of -57 cents, missing the estimate of -44 cents. With 86.46K shares outstanding, the current market capitalization sits at 53.83M.